N/A
N=128
Phone-Based Postpartum Continuing Care for Smoking Cessation
Smoking Cessation · Pregnancy
Bottom Line
View on ClinicalTrials.gov: NCT01684592 ↗Enrolled (actual)
128
Serious AEs
3.9%
Results posted
Mar 2018
Primary outcome: Primary: Number of Tobacco Products Per Day — 6.4; 6.9 tobacco products
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Phone-based postpartum continuing care (Behavioral); Standard care (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- Female
- Sponsor
- Battelle Memorial Institute
- Primary completion
- Mar 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Tobacco Products Per Day |
7.1; 7.9 | — |
| SECONDARY Number of Tobacco Products Per Day |
7.1; 7.9 | — |
| SECONDARY Past 90-day Tobacco Use |
59.2; 55.3 | — |
| SECONDARY Past 90-day Tobacco Use |
59.2; 55.3 | — |
| SECONDARY Times Mother Smoked While Breastfeeding |
7.13; 0 | — |
| SECONDARY Times Mother Smoked in the Room With Infant |
.70; .06 | — |
| SECONDARY NicCheck Test Results for Cotinine Level From Infant Urine |
0; 0 | — |
Summary
Smoking is a leading cause of death and other negative health outcomes. While a high percentage of women quit smoking during pregnancy, the majority relapse in the first 6 months postpartum. We propose developing and pilot testing a phone-based postpartum continuing care (PPCC) protocol based on existing evidence-based approaches to increase smoking cessation, reduce relapse, increase early re-intervention, and reduce infant exposure to environmental tobacco smoke in the postpartum period.
Eligibility Criteria
Inclusion Criteria
- first or second trimester of pregnancy
- age 18 or older
- self-reported tobacco use in the past 90 days or nicotine-dependence in the past year
Exclusion Criteria
- intend to terminate their pregnancy
- intend to move out of the city within the next 12 months
- are unable to provide informed consent and participate in English
Data sourced from ClinicalTrials.gov (NCT01684592). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.